Sample size considerations for assessing individual bioequivalence based on the method of tolerance intervals

Area of Science:

• Pharmacokinetics and Biopharmaceutics
• Statistical Methods in Drug Development

Background:

• Bioequivalence studies are crucial for generic drug approval.
• Accurate sample size determination is essential for study validity and efficiency.
• Tolerance intervals offer a robust statistical framework for bioequivalence assessment.

Purpose of the Study:

• To evaluate sample size calculation methods for individual bioequivalence.
• To compare direct and indirect statistical approaches for sample size determination.
• To provide practical guidance for designing bioequivalence studies.

Main Methods:

• The study considers sample size calculations based on tolerance intervals.
• It discusses three methods: direct distribution-free, indirect parametric, and direct parametric.
• Design considerations are analyzed, particularly from the direct parametric method's results.

Main Results:

• The direct parametric method provides a basis for design considerations.
• Tables are included for straightforward access to sample size results.
• The comparison of methods informs the selection of appropriate sample sizes.

Conclusions:

• The presented methods and tables facilitate the determination of optimal sample sizes for bioequivalence studies.
• Statistical considerations are key to ensuring reliable bioequivalence assessments.
• This work supports efficient and valid drug development processes.